These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 7527504)
1. Persistence of antibodies to hepatitis C virus in a chronic hemodialysis population. Carrera F; Silva JG; Oliveira C; Frazao JM; Pires C Nephron; 1994; 68(1):38-40. PubMed ID: 7527504 [TBL] [Abstract][Full Text] [Related]
2. Non-A, non-B hepatitis: clinical laboratory course in patients on hemodialysis and its correlation with the presence of anti-hepatitis C virus antibodies. La Russa A; Bufano G; Cauzzi L; Pecchini P Nephron; 1992; 61(3):273-5. PubMed ID: 1323770 [TBL] [Abstract][Full Text] [Related]
3. Prevalence of hepatitis C virus antibodies in hemodialysis patients and dialysis staff. Fujiyama S; Kawano S; Sato S; Tanaka M; Goto M; Taura Y; Sato T; Kawahara T; Mizuno K Hepatogastroenterology; 1992 Apr; 39(2):161-5. PubMed ID: 1378811 [TBL] [Abstract][Full Text] [Related]
4. Hepatitis C infection in potential recipients with normal liver biochemistry does not preclude renal transplantation. Kazi S; Prasad S; Pollak R; Holzer T; Heynen C; Fabrega AJ; Pitrak D; Layden TJ Dig Dis Sci; 1994 May; 39(5):961-4. PubMed ID: 7513631 [TBL] [Abstract][Full Text] [Related]
5. Occult hepatitis B virus infection among chronic hemodialysis patients in Alexandria, Egypt. Helaly GF; El Ghazzawi EF; Shawky SM; Farag FM J Infect Public Health; 2015; 8(6):562-9. PubMed ID: 26026236 [TBL] [Abstract][Full Text] [Related]
6. Anti-c100 antibodies to hepatitis C virus in patients with chronic hepatitis C virus infection treated with interferon. Nakano Y; Kiyosawa K; Sodeyama T; Tanaka E; Yoshizawa K; Furuta K; Nakatsuji Y; Urushihara A; Furuta S Scand J Gastroenterol; 1993 Apr; 28(4):335-42. PubMed ID: 8387696 [TBL] [Abstract][Full Text] [Related]
7. Antibodies to hepatitis C virus (HCV) and transaminase concentration in chronic haemodialysis patients: a study with second-generation assays. Fabrizi F; Raffaele L; Bacchini G; Guarnori I; Pontoriero G; Erba G; Locatelli F Nephrol Dial Transplant; 1993; 8(8):744-7. PubMed ID: 7692356 [TBL] [Abstract][Full Text] [Related]
8. Antibodies to hepatitis C virus (HCV) in chronic renal failure (CRF) patients on conservative therapy: prevalence, risk factors and relationship to liver disease. Fabrizi F; Marcelli D; Bacchini G; Guarnori I; Erba G; Locatelli F Nephrol Dial Transplant; 1994; 9(7):780-4. PubMed ID: 7526275 [TBL] [Abstract][Full Text] [Related]
9. Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients. Yakaryilmaz F; Gurbuz OA; Guliter S; Mert A; Songur Y; Karakan T; Keles H Ren Fail; 2006; 28(8):729-35. PubMed ID: 17162434 [TBL] [Abstract][Full Text] [Related]
10. [Anti-HCV in patients without risk factors for hepatitis C. Prospective study in 200 patients]. Albornoz A; Esaa R; Rodríguez de Leon L; Mujica C G E N; 1993; 47(3):136-8. PubMed ID: 7509301 [TBL] [Abstract][Full Text] [Related]
11. Decreased serum aminotransferase activity in patients with chronic renal failure: impact on the detection of viral hepatitis. Fabrizi F; Lunghi G; Finazzi S; Colucci P; Pagano A; Ponticelli C; Locatelli F Am J Kidney Dis; 2001 Nov; 38(5):1009-15. PubMed ID: 11684554 [TBL] [Abstract][Full Text] [Related]
12. Antibodies against non-structural c100/3 and structural core antigen of hepatitis C virus (HCV) in hemodialysis patients. Yoshida CF; Takahashi Y; Vanderborght BO; Rouzere CD; França MS; Takahashi C; Takamizawa A; Yoshida I; Schatzmayr HG Rev Inst Med Trop Sao Paulo; 1993; 35(4):315-21. PubMed ID: 7509506 [TBL] [Abstract][Full Text] [Related]
13. Risk factors and clinical expression of HCV infection in hemodialysis patients. Pauri P; Salvoni G; Vitolo W; Carletti P; Fanciulli E; Ricciatti AM; Della Bella S; Mioli VA Nephron; 1992; 61(3):313-4. PubMed ID: 1323778 [TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus antibody positive blood donors. Mutimer D; Shaw J; Harrison R; Ala F; Neuberger J; Elias E Gut; 1993; 34(2 Suppl):S54. PubMed ID: 7686116 [TBL] [Abstract][Full Text] [Related]
15. Influence of hepatitis C virus (HCV) viraemia upon serum aminotransferase activity in chronic dialysis patients. Fabrizi F; Lunghi G; Andrulli S; Pagliari B; Mangano S; Faranna P; Pagano A; Locatelli F Nephrol Dial Transplant; 1997 Jul; 12(7):1394-8. PubMed ID: 9249775 [TBL] [Abstract][Full Text] [Related]
16. Comparison of anti-hepatitis C virus detection with ELISA assay and RIBA 4 in dialysis patients: our experience. Innocenti M; Mazzoni A; Moretti A; Palla P Nephron; 1992; 61(3):315. PubMed ID: 1380132 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic Dilemmas in Hepatitis C Virus Infection for Hemodialysis Patients. Komitova RT; Atanasova MV; Pavlova TA; Nyagolov MS; Ivanova AV Folia Med (Plovdiv); 2017 Mar; 59(1):70-77. PubMed ID: 28384106 [TBL] [Abstract][Full Text] [Related]
18. [Evaluation of the patients with low levels of anti-HCV positivity]. Zer Y; Karaoğlan I; Ciçek H; Karağoz ID; Sağlam M Mikrobiyol Bul; 2009 Jan; 43(1):133-9. PubMed ID: 19334390 [TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus infection in hemodialyzed patients detected by first and second generation assays. Ruffatti A; Bortolotti F; Bianco A; Pizzulli N; Cavalletto D; Alberti A; Romagnoli GF Nephron; 1992; 61(3):344-5. PubMed ID: 1380133 [TBL] [Abstract][Full Text] [Related]
20. Prevalence of antibodies to hepatitis C virus in patients receiving renal replacement therapy, and in the staff caring for them. Blackmore TK; Stace NH; Maddocks P; Hatfield P Aust N Z J Med; 1992 Aug; 22(4):353-7. PubMed ID: 1280095 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]